Our methodology research at the SCT annual conference 2023
19 May 2023
Sunday 21st May marks the beginning of the 44th Annual Meeting of the Society for Clinical Trials, where several researchers from the MRC Clinical Trials at UCL will be presenting their latest work.
We will give a range of presentations on new developments in clinical trials methodology, including talks, discussions (both panel discussions and roundtable discussions) and a pre-conference workshop.
SCT is an international organisation that advocates for the use of clinical trials to advance human health. Its members include representatives from academia, the pharmaceutical and device industries, government agencies, medical groups and centres, and clinical research entities. The SCT annual meeting is one of the largest gatherings of people to share research on how to improve clinical trials.
The conference will take place from Sunday 21 May to Wednesday 24 May in Baltimore, MD, USA.
The theme for this year’s meeting is “Championing high-quality evidence to optimise human health”.
Details of the MRC CTU at UCL presentations taking place at the conference are shown below.
| Time (ET) | Session | Title | Speaker | Place | |
| Sunday 21st May | 1PM - 5PM | PRE-CONFERENCE WORKSHOP 5 | Statistical and practical aspects of the design and analysis of Multi-Arm Multi-Stage (MAMS) Platform Trials |
Babak Choodari-Oskooei Max Parmar Matt Sydes |
Harborside Ballroom Salon E (Level 4) |
| Monday 22nd May | 11:30AM – 12:45PM | ROUNDTABLE 6 | Estimands in Clinical Trials | Brennan Kahan | Heron (Level 4) |
| 12:45PM – 2:15PM | INVITED SESSION 6 | Advancing Causal Inference Methods for Cluster Randomized Trials | Brennan Kahan | Harborside Ballroom Salon E (Level 4) | |
| 2:45AM - 4:15PM | INVITED SESSION 9 | The What and the How: Practical Challenges in Aligning Estimands and Estimation Using Tuberculosis as a Case Study | Tra My Pham | Harborside Ballroom Salons ABC (Level 4) | |
| Tuesday 23rd May | 9:30AM - 10:30AM | CONTRIBUTED SESSION 5: Reporting | Methodology and Results of the CONSORT and SPIRIT Extensions for Factorial Trials | Brennan Kahan | Harborside Ballroom Salons ABC (Level 4) |
| 10:45AM- 11:45AM | CONTRIBUTED SESSION 7: MAMS/Adaptive | The Multi-Arm Multi-Stage Response Over Continuous Intervention (MAMS-ROCI) design: a practical design to optimise treatment administration | Matteo Quartagno | Harborside Ballroom Salon E (Level 4) | |
| 10:45AM - 11:45AM | CONTRIBUTED SESSION 7: MAMS/Adaptive | Optimizing multi-arm multi-stage platform randomised clinical trials in the phase III setting: with applications to the ROSSINI 2 (surgical) trial | Babak Choodari-Oskooei | Harborside Ballroom Salon E (Level 4) | |
| 10:45AM – 11:45AM | CONTRIBUTED SESSION 8: Survival Analysis | Estimation of Restricted Mean Survival Time under proportional hazards in Non-Inferiority trials |
Matteo Quartagno | Laurel (Level 4) | |
| 2:30PM - 4PM | INVITED SESSION 15 | Academic-led trials for regulatory use |
Max Parmar Matt Sydes |
Harborside Ballroom Salons ABC (Level 4) |
Check out the full programme on the SCT website or the #SCT2023 app.
MRC CTU at UCL attendees may be tweeting from: @mattsydes, @stats_q, @Brennan_Kahan, @BabakOskooei, @t_mpham, @MaxParmarMRCUCL
Further information: